Asia Pacific Prefilled Syringes Market worth $3.14 billion by 2030
The report "Asia Pacific Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030", is projected to reach USD 3.14 billion by 2030 from USD 1.75 billion in 2025, at a CAGR of 12.4% during the forecast period
Browse 150 market data Tables and 60 Figures spread through 200 Pages and in-depth TOC on "Asia Pacific Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-prefilled-syringes-market-159611064.html
The growth of the Asia Pacific prefilled syringes market is primarily driven by the rising prevalence of chronic diseases requiring long-term therapies, coupled with the growing elderly population globally, and the increasing adoption of biological drugs, which often require precise dosing and administration. However, stringent regulations for approval processes and safety issues associated with pre-filled syringes can affect market growth, requiring continuous innovation and rigorous testing to overcome these barriers.
Conventional prefilled syringes segment is expected to account for the largest share of the Asia Pacific prefilled syringes market during the forecast period.
The conventional prefilled syringes segment holds the largest share of the Asia Pacific prefilled syringes market, driven by widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment's dominance is driven by its versatility and by established manufacturing processes that support large-scale production to effectively meet global healthcare demands. Conventional prefilled syringes account for a significant share of the prefilled syringes segment because they are widely used across various therapeutic applications. These syringes are prefilled with a specific dosage of medication, ensuring ease of use and precise doses for healthcare providers and patients. They are user-friendly, have a reduced chance of contributing to contamination, and are compatible with a variety of drugs. The versatility of this segment complements established manufacturing methods in high-scale production to ensure adequate supply to healthcare needs.
Glass prefilled syringes segment is expected to account for the largest share of the Asia Pacific prefilled syringes market during the forecast period.
The glass prefilled syringes segment holds the largest share of the Asia Pacific prefilled syringes market due to their superior material properties, which enable them to handle sensitive drug formulations. Glass syringes offer multiple benefits, including their inert nature, which reduces the risk of drug interactions and leaching. They are the best choice for all biologics, vaccines, and other complex drug formulations. Glass syringes provide a clear view of their contents, enabling precise measurement of medication dosages. Glass syringes are weaker than plastic syringes, yet advances in glass technology have enhanced their safety and durability, supporting glass syringe market supremacy.
Single-chamber prefilled syringes segment is expected to account for the largest share of the Asia Pacific prefilled syringes market during the forecast period.
The single-chamber prefilled syringes segment accounts for the largest share of the Asia Pacific prefilled syringe market on account of its simplicity and low cost for drug delivery. A single-compartment prefilled syringe is a device that is prefilled with a medication in one chamber, thus making it very easy to manufacture and operate. For the convenience of users and minimized risk of medication errors, these types of syringes are extensively used in different therapeutic areas, vaccine delivery, and insulin administration.
Cancer segment is expected to account for the largest share of the Asia Pacific prefilled syringes market during the forecast period.
The cancer segment holds the largest share in the Asia Pacific prefilled syringes market, driven by the rising prevalence of cancer and the demand for precise, targeted drug delivery systems. Among the significant advantages of prefilled syringes in oncology treatments are accurate dosing, reduced risk of contamination, and superior patient compliance. They can be used to deliver chemotherapeutics, monoclonal antibodies, and supportive care drugs, enabling tailored therapy and better patient outcomes. This segment's performance underscores the indispensable role of prefilled syringes in advanced cancer treatments and ongoing innovations to address specific oncological conditions.
In 2024, Japan accounted for the largest share of the Asia Pacific prefilled syringes market.
The Asia Pacific prefilled syringes market, by country, is segmented into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. Japan holds the highest share in the Asia Pacific prefilled syringes market, thanks to its highly advanced healthcare infrastructure, widespread use of advanced medical technology, and significant investments in pharmaceutical research and development. The market is also fueled by a highly regulated environment that encourages the use of prefilled syringes for the safe, accurate, and efficient administration of drugs. In addition, the growing geriatric population and increasing prevalence of chronic diseases in Japan are fueling the demand for injectable drugs. The presence of prominent pharmaceutical and biotechnology firms also cements Japan’s position in the Asia Pacific market.
Key Market Players :
The key players in the Asia Pacific prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Medical international Co., Ltd. (China), Credence MedSystems, Inc.(US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), and Sharps Technology, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Prefilled Syringes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
